TGFB1 and breast carcinoma: CAFs-derived TGF-β drives EMT and enhances fibronectin, vimentin, MMP-2/9, SNAIL, and TWIST expression, promoting breast cancer cell motility, drug resistance, and stemness via upregulation of lncRNA HOTAIR, silencing tumor suppressor genes.